Cosmetic dermatology uses evidence-based procedures to change or improve the appearance of skin, hair, and facial features. Today’s treatments combine controlled injury, energy-based devices, and injectable medicines to address concerns such as wrinkles, pigment, scars, and volume loss. Their popularity makes safety and realistic expectations important: the American Society of Plastic Surgeons reported about 25.4 million minimally invasive cosmetic procedures in the United States in 2023. This overview explains how the main treatment categories work, what evidence can—and cannot—show, and how to make informed choices.
How Cosmetic Dermatology Treatments Work
Cosmetic dermatology is the medical field concerned with improving appearance through skin care, medicines, injections, and procedures. The American Academy of Dermatology describes dermatologists as physicians trained to diagnose and treat conditions affecting skin, hair, and nails; cosmetic procedures apply that expertise to aesthetic goals. Treatment effects are not interchangeable: some temporarily relax facial muscles, others add volume, and still others prompt tissue remodeling or remove selected pigment.
A useful way to understand the science is to group procedures by their biological target: neuromuscular activity, structural volume, or skin tissue and pigment. The expected result depends on the target, treatment settings, the patient’s health and anatomy, and the practitioner’s judgment. “Non-surgical” does not mean risk-free, and results vary.
Evidence, selection, and limits
Evidence for a procedure can include controlled clinical studies, regulatory review, professional guidance, and post-market safety monitoring. The U.S. Food and Drug Administration (FDA) evaluates medicines and devices for specific intended uses; approval or clearance should not be interpreted as proof that a treatment is suitable for every person or every use. Patients should ask what evidence supports the proposed treatment for their particular concern, what alternatives exist, and how long benefits are expected to last.
Injectables: Muscle Relaxation and Restored Volume
Injectables are medicines or materials placed into or beneath the skin. The two major groups are botulinum toxin products, which temporarily reduce muscle activity, and dermal fillers, which add volume or support. The FDA notes that fillers are medical devices and that their risks depend on material, location, and technique. A careful assessment distinguishes expression-related lines from volume loss because the treatments address different causes.
Botulinum toxin for dynamic wrinkles
Botulinum toxin type A is a prescription medicine that temporarily blocks nerve signals to selected muscles. By reducing muscle contraction, it can soften dynamic lines—creases that become more visible during facial movement. Effects generally develop over several days and commonly last about three to four months, although response varies by product, dose, treated area, and individual.
In the FDA’s 2024 safety communication, the agency reiterated that approved botulinum toxin products are prescription medicines and warned that unapproved or improperly sourced products can pose serious risks. Possible adverse effects include bruising, headache, eyelid or brow droop, and, rarely, spread of toxin effects causing swallowing or breathing difficulty. Treatment should be performed by a qualified, licensed clinician using an authorized product.
Dermal fillers for volume and contour
Dermal fillers are injectable materials used to soften folds, restore selected areas of volume, or shape facial contours. Hyaluronic acid fillers are among the most widely used; other FDA-approved materials include calcium hydroxylapatite and poly-L-lactic acid, each with different properties and indications. Some hyaluronic acid products can be dissolved with an enzyme, but reversibility is not a guarantee against complications.
Most filler effects are temporary, with duration varying by material and treatment site. Common effects include swelling, tenderness, and bruising. A rare but severe complication occurs when filler enters or compresses a blood vessel, potentially causing tissue injury, vision impairment, or stroke. The FDA advises that filler injections be treated as medical procedures—not casual services—and that patients discuss the specific product, risks, and emergency plan beforehand.
Energy-Based Devices and Skin Resurfacing
Energy-based treatments deliver light, laser energy, radiofrequency, or controlled mechanical injury to selected skin structures. Their purpose may be to reduce unwanted pigment or visible vessels, improve texture, or stimulate collagen remodeling. Devices differ in wavelength, energy, depth, and cooling, so the same broad label—such as “laser”—does not describe a single treatment or risk profile.
Lasers and intense pulsed light
Lasers emit concentrated light at selected wavelengths, while intense pulsed light (IPL) delivers a broader range of wavelengths through filtered pulses. Clinicians choose a device based on the target, such as pigment, blood vessels, hair follicles, or water in tissue. Fractional devices treat microscopic columns while leaving surrounding tissue relatively intact; ablative procedures remove more surface tissue and generally require more healing than non-ablative approaches.
Potential harms include burns, scarring, infection, and temporary or persistent changes in skin color. The American Academy of Dermatology emphasizes that darker skin tones can be more vulnerable to certain pigment changes after procedures, making device selection and operator experience especially important. A consultation should cover skin type, recent tanning, medications, prior scarring, eye protection, expected downtime, and sun avoidance during recovery.
Microneedling and radiofrequency
Microneedling uses fine needles to create controlled micro-injuries that activate wound-healing responses and can encourage collagen production. Radiofrequency microneedling adds thermal energy through needles to heat deeper tissue. These procedures may be considered for texture, acne scars, or selected signs of aging, but outcomes depend on device, treatment protocol, scar type, and clinician skill.
The FDA has issued safety communications about radiofrequency microneedling, including reports of burns, scarring, fat loss, disfigurement, and nerve damage. The agency stresses that these devices are medical devices and should be used by trained, licensed health professionals. Patients should disclose active skin infections, a history of keloids, and relevant medical conditions, and should avoid using unapproved devices or performing treatments at home.
Chemical Peels and Medical Skin Care
Chemical peels apply a chemical solution to remove controlled layers of skin, prompting regeneration. Superficial peels generally act in the outermost layers, while medium and deep peels reach further and involve greater recovery and risk. A peel may be used for selected concerns such as uneven tone, fine lines, or acne-related changes, but it cannot reliably erase every scar or prevent aging.
Peel depth, aftercare, and skin tone
The American Academy of Dermatology explains that peel depth influences both results and recovery: light peels may require repeated sessions, while deeper peels can involve longer healing and more substantial risks. Redness, irritation, infection, scarring, and changes in pigmentation are possible. The choice of agent and depth should account for skin tone, prior treatments, medications, and a history of cold sores or abnormal scarring.
Daily skin care as the foundation
Medical-grade procedures work best within a practical skin-care plan rather than as substitutes for basic skin protection. The American Academy of Dermatology recommends broad-spectrum sunscreen with SPF 30 or higher, along with shade and protective clothing. Sunscreen helps reduce ultraviolet exposure that contributes to skin aging and skin cancer; it also supports recovery and helps limit post-procedure pigment changes. A dermatologist can advise on active ingredients such as retinoids or pigment-targeting medicines, which may irritate skin and are not appropriate for everyone.
Choosing a Treatment and Managing Risk
A sound treatment plan begins with a medical consultation, not a device or product promotion. The clinician should identify the concern, review medical history and medications, explain alternatives, and set realistic goals. The American Society of Plastic Surgeons’ 2023 statistics recorded approximately 25.4 million minimally invasive procedures in the United States, including about 9.5 million neuromodulator treatments and 5.3 million hyaluronic acid filler procedures. These figures indicate widespread use; they do not establish that a procedure is necessary or appropriate for an individual.
Questions to ask before treatment
- What is the clinician’s relevant license, training, and experience with this exact procedure?
- Which product or device will be used, and is it authorized for the proposed purpose?
- What benefits are realistic, how long might they last, and what alternatives—including no treatment—are reasonable?
- What are the common and serious risks, and how will complications be handled?
- What preparation, recovery time, follow-up, and total cost should be expected?
Seek urgent medical care for severe or rapidly worsening pain, skin blanching or dusky discoloration after filler, sudden vision changes, difficulty breathing or swallowing, or signs of serious infection. These symptoms require prompt assessment rather than routine follow-up.
Conclusion: Evidence, Expertise, and Individualized Care
Today’s cosmetic dermatology treatments act through distinct mechanisms: injectables alter muscle activity or add volume, energy-based devices target skin structures, and peels renew selected surface layers. Their expanding use makes informed selection essential. Evidence and regulatory status, appropriate patient selection, skilled treatment, and careful aftercare all shape the balance of benefit and risk. Anyone considering a procedure should consult a qualified medical professional, verify credentials and product details, and seek evidence-based guidance rather than relying on popularity or guaranteed-result claims.
Sources: American Society of Plastic Surgeons, 2023 Plastic Surgery Statistics Report, https://www.plasticsurgery.org/news/plastic-surgery-statistics; U.S. Food and Drug Administration, Dermal Fillers (Soft Tissue Fillers), https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers; U.S. Food and Drug Administration, Botulinum Toxin Products, https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/botulinum-toxin-products; U.S. Food and Drug Administration, FDA Safety Communication: Radiofrequency Microneedling Devices, https://www.fda.gov/medical-devices/safety-communications/fda-warns-about-potential-risks-certain-uses-radiofrequency-rf-microneedling-devices-and; American Academy of Dermatology, Laser Resurfacing, https://www.aad.org/public/cosmetic/younger-looking/laser-resurfacing; American Academy of Dermatology, Chemical Peels: FAQs, https://www.aad.org/public/cosmetic/younger-looking/chemical-peels-faqs; American Academy of Dermatology, Sunscreen FAQs, https://www.aad.org/media/stats-sunscreen; U.S. Food and Drug Administration, Microneedling Devices: Getting to the Point on Benefits, Risks and Safety, https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/microneedling-devices-getting-point-benefits-risks-and-safety.
